D 500 (Daliresp 500 mcg)
Generic Name: roflumilast
Pill with imprint D 500 is White, Round and has been identified as Daliresp 500 mcg. It is supplied by AstraZeneca Pharmaceuticals LP.
Daliresp is used in the treatment of copd, maintenance; copd and belongs to the drug class selective phosphodiesterase-4 inhibitors. Risk cannot be ruled out during pregnancy. Daliresp 500 mcg is not a controlled substance under the Controlled Substances Act (CSA).
Images for D 500
Daliresp
- Generic Name
- roflumilast
- Imprint
- D 500
- Strength
- 500 mcg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Selective phosphodiesterase-4 inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca Pharmaceuticals LP
- Inactive Ingredients
-
lactose monohydrate,
corn starch,
povidone,
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00456-0095 (Discontinued) | Forest Laboratories, LLC |
| 00310-0095 | AstraZeneca |
Related images for "D 500"
More about Daliresp (roflumilast)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (62)
- Drug images
- Pricing & coupons
- Generic availability
- En español
- Drug class: selective phosphodiesterase-4 inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.